Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results From Phase I of the Texas Coronavirus Antibody Response Survey

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and immunity remains uncertain in populations. The state of Texas ranks 2nd in infection with over 2.71 million cases and has seen a disproportionate rate of death across the state. The Texas CARES project was funde...

Descripción completa

Detalles Bibliográficos
Autores principales: Valerio-Shewmaker, Melissa A., DeSantis, Stacia, Swartz, Michael, Yaseen, Ashraf, Gonzalez, Michael O., Kohl, Harold W. III, Kelder, Steven H., Messiah, Sarah E., Aguillard, Kimberly A., Breaux, Camille, Wu, Leqing, Shuford, Jennifer, Pont, Stephen, Lakey, David, Boerwinkle, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712464/
https://www.ncbi.nlm.nih.gov/pubmed/34970525
http://dx.doi.org/10.3389/fpubh.2021.753487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712464/
https://www.ncbi.nlm.nih.gov/pubmed/34970525
http://dx.doi.org/10.3389/fpubh.2021.753487

Ejemplares similares